Sponsor Pipeline

Nanjing Reju Therapeutics Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07521748 A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of RC017… Dry Eye Not Yet Recruiting
NCT07528703 A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics… IPF Not Yet Recruiting
Disease Areas
Idiopathic Pulmonary Fibrosis (1)
Get alerts when Nanjing Reju Therapeutics Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free